Cogent Biosciences, Inc. (COGT)

NASDAQ: COGT · Real-Time Price · USD

Compare

36.53

-0.19 (-0.52%)

At close: Feb 13, 2026, 4:00 PM EST

36.75

+0.22 (0.60%)

After-hours: Feb 13, 2026, 7:59 PM EST

Cogent Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	-	-	-	-	-	7.87
Revenue Growth (YoY)	-	-	-	-	-	-65.02%
Cost of Revenue	-	-	-	-	-	25.74
Gross Profit	-	-	-	-	-	-17.87
Selling, General & Admin	51.34	43.28	34.38	26.21	19.64	17.42
Research & Development	256.27	232.66	173.76	121.63	55.91	-
Operating Expenses	307.6	275.94	208.13	147.84	75.55	17.42
Operating Income	-307.6	-275.94	-208.13	-147.84	-75.55	-35.29
Interest & Investment Income	13.07	18.09	13.08	3.99	0.47	0.14
Other Non Operating Income (Expenses)	6.04	1.99	2.64	3.61	2.81	-0.25
EBT Excluding Unusual Items	-290.26	-255.86	-192.41	-140.24	-72.27	-35.39
Gain (Loss) on Sale of Assets	-	-	-	-	-	7.49
Pretax Income	-294.37	-255.86	-192.41	-140.24	-72.27	-74.81
Earnings From Continuing Operations	-	-255.86	-192.41	-140.24	-72.27	-74.81
Net Income	-294.37	-255.86	-192.41	-140.24	-72.27	-74.81
Preferred Dividends & Other Adjustments	-	-	-	-	-	104.4
Net Income to Common	-294.37	-255.86	-192.41	-140.24	-72.27	-179.21
Shares Outstanding (Basic)	119	104	80	59	39	11
Shares Outstanding (Diluted)	119	104	80	59	39	11
Shares Change (YoY)	21.79%	30.36%	35.54%	51.89%	249.52%	45.42%
EPS (Basic)	-2.47	-2.46	-2.41	-2.38	-1.87	-16.17
EPS (Diluted)	-2.47	-2.46	-2.41	-2.38	-1.87	-16.17
Free Cash Flow	-246.73	-208.36	-156.42	-125.5	-60.48	-35.85
Free Cash Flow Per Share	-2.07	-2.00	-1.96	-2.13	-1.56	-3.23
Gross Margin	-	-	-	-	-	-227.00%
Operating Margin	-	-	-	-	-	-448.34%
Profit Margin	-	-	-	-	-	-2276.81%
Free Cash Flow Margin	-	-	-	-	-	-455.47%
EBITDA	-305.04	-273.49	-205.86	-147	-75.4	-34.57
D&A For EBITDA	2.56	2.45	2.27	0.84	0.15	0.72
EBIT	-307.6	-275.94	-208.13	-147.84	-75.55	-35.29

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q